Semalgid 4mg – Semaglutide – Ozempic pen
Semaglutide details and the ozempic pen
Active ingredient: semiglutide
Category: GLP-1 (glucagon-like peptide-1) receptor agonist
Dosage form: Injectable solution
- Spedizione (se il prodotto è in stock): 3 giorni lavorativi di processing e dai 5 ai 20 giorni lavorativi di spedizione
- Spese di Processing e spedizione: 27€ in tutta Italia
Understanding Ozempic and Semaglutide
Ozempic is the brand name of semiglutide, a drug used in the treatment of type 2 diabetes. It belongs to the class of GLP-1 receptor agonists, molecules that mimic the action of a natural hormone involved in regulating blood sugar and appetite.
Besides managing diabetes, Ozempic (Semaglutide) is used for weight management in selected individuals. Its ability to reduce appetite and improve insulin sensitivity promotes weight loss.
How the drug works
The semiglutide, the active ingredient in Ozempic, works by mimicking the GLP-1 hormone and helps control blood sugar levels through several mechanisms:
- stimulates insulin secretion in the presence of high blood sugar levels
- reduces glucose production by the liver
- slows gastric emptying, increasing the feeling of fullness
- reduces appetite and total calorie intake
Primary medical benefits
The use of Ozempic offers benefits to both patients with diabetes and those who need help managing their weight:
- Better blood glucose control, lowering blood glucose levels
- Weight Loss, helping reduce appetite and calorie intake
- Cardiovascular Protection, clinical studies indicate a reduced risk of heart attack, stroke, and major cardiovascular events
- Weekly administration, just one injection per week improves treatment adherence
- Low risk of hypoglycemia, when used alone, it poses a lower risk than other antidiabetic medications
Reported side effects
Like all medications, Ozempic (semiglutide) may cause side effects, which are generally mild and temporary:
- nausea
- vomit
- diarrhea or constipation
- abdominal pain
- indigestion
- Headache
- fatigue
- reduced appetite
Rarer but serious side effects may include pancreatitis, kidney problems, and a potential increased risk of thyroid cancer. It is always advisable to discuss this with a doctor.
Administration guidelines
Semaglutide is administered via A subcutaneous injection once a week. The dosage is gradually increased to improve tolerability:
- Starting dose: 0.25 mg once a week for 4 weeks (adjustment phase)
- Maintenance dose: 0.5 mg once a week
- Increase in dosage : If necessary, the dose may be increased to 1 mg after at least 4 weeks
- Maximum dose: in some cases, up to 2 mg per week, under a doctor’s supervision
Safety precautions
- Stop taking the medication if Pancreatitis is suspected
- Use caution in patients with diabetic retinopathy
- monitor kidney function, especially in cases of dehydration
- a possible increase in the risk of gallstones
- increased risk of hypoglycemia when combined with insulin or insulin secretagogues
Storage instructions
- Before use: Store in the refrigerator at 2–8°C , do not freeze.
- After opening: Use by 56 days at a temperature of ≤30°C or in the refrigerator
- protect from light, heat, children, and animals
- never freeze
Ozempic (Semaglutide) is an option for blood sugar and weight control, with a safety profile supported by clinical studies.
You must be logged in to post a review.















Reviews
There are no reviews yet.